Page last updated: 2024-10-21

4,5,6,7-tetrabromo-2-azabenzimidazole and Tauopathies

4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with Tauopathies in 1 studies

4,5,6,7-tetrabromobenzotriazole: a CK2 kinase inhibitor

Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.

Research Excerpts

ExcerptRelevanceReference
"Tauopathies are a class of neurodegenerative disorders characterized by abnormal deposition of post-translationally modified tau protein in the human brain."1.56Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization. ( Aiello, G; Kobeissy, F; Kurup, M; Lin, F; Torres, I; Wang, KK; Yadikar, H; Yang, Z; Yost, R, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yadikar, H1
Torres, I1
Aiello, G1
Kurup, M1
Yang, Z1
Lin, F1
Kobeissy, F1
Yost, R1
Wang, KK1

Other Studies

1 other study available for 4,5,6,7-tetrabromo-2-azabenzimidazole and Tauopathies

ArticleYear
Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.
    PloS one, 2020, Volume: 15, Issue:7

    Topics: Animals; Cell Line; Cyclosporine; Glycogen Synthase Kinase 3; Lithium Chloride; Mice; Models, Biolog

2020